TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function
NCT: NCT07825688 · NOT_YET_RECRUITING
Brief Summary
This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.
Frequently Asked Questions
What is TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function?
TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function is a clinical trial registered under NCT07825688. Current status: NOT_YET_RECRUITING.
What is the status of NCT07825688?
The current status of NCT07825688 (TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function) is: NOT_YET_RECRUITING.
When did TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function start?
TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function started on 2026-09-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.